A randomized controlled phase 2 trial comparing the safety and usefulness of robot-assisted esophagectomy and thoracoscopic

Phase 2

Recruiting

• Conditions: esophageal cancer and gastroesophageal junction cancer; Roboto-assisted esophagectomy; D004938

• Registration Number: JPRN-jRCT1040220153
• Lead Sponsor: Takeuchi Hiroya

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-02-28
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Intended for patients who meet all of the following criteria
1.Patients over 18 years old
2. Patients diagnosed with esophageal or gastroesophageal junction cancer
3. Patients scheduled for subtotal thoracic esophagectomy with bilateral recurrent laryngeal perineural lymph node (#106recR and #106recL) dissection
4. Those who have obtained consent to participate in this research by signing a consent form by themselves or their proxy

Exclusion Criteria

Patients who meet any of the following conditions will not be included in this study.
1. Subjects with recurrent laryngeal nerve palsy before surgery
2. Patients with heart disease (NYHA III-IV, severe arrhythmia)
3. Subjects with severe liver disorder (fulminant hepatitis, hepatic encephalopathy, Child-Pugh classification Grade C)
4. Subjects with severe renal impairment (chronic kidney disease stage 4 or 5 according to CKD guidelines)
5. Women who are pregnant or may become pregnant
6. breastfeeding woman
7. Subjects with dementia
8. Those judged inappropriate by the investigator

Study & Design

• Study Type: Interventional
• Study Design: Not specified